Using Metamodeling to Identify the Optimal Strategy for Colorectal Cancer Screening.
暂无分享,去创建一个
Hendrik Koffijberg | Koen Degeling | Maarten Joost IJzerman | Veerle M.H. Coupé | Marjolein J.E. Greuter | M. IJzerman | H. Koffijberg | V. Coupé | M. Greuter | K. Degeling
[1] Karl Claxton,et al. Addressing Adoption and Research Design Decisions Simultaneously , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] Timothy W. Simpson,et al. Metamodels for Computer-based Engineering Design: Survey and recommendations , 2001, Engineering with Computers.
[3] G. Meijer,et al. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy , 2017, Annals of Internal Medicine.
[4] Anne Eisinga,et al. A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare. , 2012, Journal of clinical epidemiology.
[5] Jeremy E. Oakley,et al. Bayesian History Matching of Complex Infectious Disease Models Using Emulation: A Tutorial and a Case Study on HIV in Uganda , 2015, PLoS Comput. Biol..
[6] J. Emery,et al. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[7] K Degeling,et al. A scoping review of metamodeling applications and opportunities for advanced health economic analyses , 2018, Expert review of pharmacoeconomics & outcomes research.
[8] Fernando Alarid-Escudero,et al. A Gaussian Approximation Approach for Value of Information Analysis , 2017, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] Bernd Bischl,et al. Resampling Methods for Meta-Model Validation with Recommendations for Evolutionary Computation , 2012, Evolutionary Computation.
[10] Jonathan Karnon,et al. Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern , 2022 .
[11] A. O'Hagan,et al. Curve Fitting and Optimal Design for Prediction , 1978 .
[12] Tiago M de Carvalho,et al. Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators , 2019, Medical decision making : an international journal of the Society for Medical Decision Making.
[13] E. Kuipers,et al. Modeling the Adenoma and Serrated Pathway to Colorectal CAncer (ASCCA) , 2014, Risk analysis : an official publication of the Society for Risk Analysis.
[14] Paul Fockens,et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. , 2012, The Lancet. Oncology.
[15] Dick den Hertog,et al. Space-filling Latin hypercube designs for computer experiments , 2008 .
[16] Jeremy E. Oakley,et al. Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[17] Jesús Fernández-Villaverde,et al. A Comparison of Programming Languages in Economics , 2015 .
[18] E. Livingston,et al. Rates of Colon and Rectal Cancers are Increasing in Young Adults , 2003, The American surgeon.
[19] Mark Strong,et al. Introduction to Metamodeling for Reducing Computational Burden of Advanced Analyses with Health Economic Models: A Structured Overview of Metamodeling Methods in a 6-Step Application Process , 2020, Medical decision making : an international journal of the Society for Medical Decision Making.
[20] Maarten J. IJzerman,et al. Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[21] J. Berkhof,et al. The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis. , 2016, The British journal of radiology.
[22] Onchee Yu,et al. A hierarchical non‐homogenous Poisson model for meta‐analysis of adenoma counts , 2007, Statistics in medicine.
[23] Fernando Alarid-Escudero,et al. The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis , 2019, PharmacoEconomics.
[24] Iftekhar A. Karimi,et al. Design of computer experiments: A review , 2017, Comput. Chem. Eng..
[25] G. Rinkel,et al. Optimal screening strategy for familial intracranial aneurysms , 2010, Neurology.
[26] G Baio,et al. BCEA: A R Package to Perform Bayesian Cost-Effectiveness Analysis. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[27] P Tappenden,et al. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis. , 2004, Health technology assessment.
[28] Hendrik Koffijberg,et al. A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models , 2017, Expert review of pharmacoeconomics & outcomes research.
[29] Nicolas Silva-Illanes,et al. Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[30] Maarten J. IJzerman,et al. Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[31] C M Mangham,et al. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up , 2011, Gut.
[32] Maarten J. IJzerman,et al. Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist , 2018, Medical decision making : an international journal of the Society for Medical Decision Making.
[33] M J Buxton,et al. Modelling in economic evaluation: an unavoidable fact of life. , 1997, Health economics.
[34] A. Zauber,et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline , 2018, Cancer.
[35] Min Xie,et al. A systematic comparison of metamodeling techniques for simulation optimization in Decision Support Systems , 2010, Appl. Soft Comput..
[36] L. Rabeneck,et al. The Global Paradigm Shift in Screening for Colorectal Cancer. , 2019, Gastroenterology.
[37] Aasma Shaukat,et al. Long-term mortality after screening for colorectal cancer. , 2013, The New England journal of medicine.